Phlogenzym (Bromelain, Flavonoid Rutoside, Trypsin)
Active Ingredient: Bromelain, Flavonoid Rutoside, Trypsin
Dosage: 90 mg/48 mg/100 mg
Route of Administration: Oral
Dosage Form: Tablets
Quantity per package: 60, 100, 200 tablets per pack
Availability: Out of stock
Phlogenzym is a preparation containing the combination of bromelain, flavonoid rutoside and trypsin. It is used to treat various inflammatory conditions (inflammations of the urinary tract and of genitals, inflammations of veins, inflammation of the locomotive system and of rheumatic diseases. The drug improves blood flow in small vessels, regulates blood circulation in tissues, accelerates healing processes and tissue regeneration, relieves pain. Phlogenzym is often used for the treatment of oedemas after injuries and surgeries. It is out of stock, at the right moment. Buy some other medications from this drug group here.
Phlogenzym is intended for its anti-inflammatory effect in the following conditions:
- dental applications;
- adjuvant in antibiotic therapy.
Dosage and administration
It is prescribed 3 to 6 tablets daily divided into 3 doses preferably one hour before the meal. The route of administration is oral. The dose can be increased without the toxicity risk. The time of administration will depend on the clinical patient’s condition. In cases of very severe processes, a higher dose may be used without requiring additional diagnostic studies or having the possibility of severe side effects.
There is no absolute contraindication to the use of Phlogenzym.
Children under 12 years old are contraindicated taking this drug.
Rarely allergic reactions have occurred, which disappear when treatment is discontinued. In isolated cases, it has been reported that Phlogenzym (Bromelain, Flavonoid Rutoside, Trypsin) may cause a change in the smell, color and/or consistency of stool. The use of this drug at high doses has caused, in very few patients, a feeling of abdominal fullness, meteorism and isolated cases of nausea.
It may provoke toxicity symptoms. The data recorded are limited.
Concomitant use of Phlogenzym with antibiotics has shown an increase in the concentration of the antibiotic at the site of infection. But no clinical observations on the interaction of Phlogenzym with other medications have been described. However, in patients undergoing anticoagulant therapy, the safety of Phlogenzym should be justified.